Anhui Huaheng Biotechnology Balance Sheet Health
Financial Health criteria checks 2/6
Anhui Huaheng Biotechnology has a total shareholder equity of CN¥1.9B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 83.6%. Its total assets and total liabilities are CN¥4.4B and CN¥2.5B respectively. Anhui Huaheng Biotechnology's EBIT is CN¥494.8M making its interest coverage ratio 81.3. It has cash and short-term investments of CN¥370.9M.
Key information
83.6%
Debt to equity ratio
CN¥1.59b
Debt
| Interest coverage ratio | 81.3x |
| Cash | CN¥370.92m |
| Equity | CN¥1.90b |
| Total liabilities | CN¥2.49b |
| Total assets | CN¥4.39b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688639's short term assets (CN¥1.2B) do not cover its short term liabilities (CN¥1.9B).
Long Term Liabilities: 688639's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥542.6M).
Debt to Equity History and Analysis
Debt Level: 688639's net debt to equity ratio (64%) is considered high.
Reducing Debt: 688639's debt to equity ratio has increased from 28.1% to 83.6% over the past 5 years.
Debt Coverage: 688639's debt is not well covered by operating cash flow (6.7%).
Interest Coverage: 688639's interest payments on its debt are well covered by EBIT (81.3x coverage).